Activation of ERG2 potassium channels by the diphenylurea NS1643

Neuropharmacology

Volumn 53, Issue 2, 2007, Pages 283-294

  Elmedyb, Pernille ^b   Olesen, Søren Peter ^a,b   Grunnet, Morten ^a,b  

^a NEUROSEARCH A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ERG1; ERG2; hERG1, IKr; NS1643; Voltage dependent potassium channels

Indexed keywords

AMIODARONE; BEPRIDIL; CHLORPROMAZINE; HALOPERIDOL; NS 1643; PIMOZIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV11.1; POTASSIUM CHANNEL KV11.2; POTASSIUM CHANNEL STIMULATING AGENT; TERFENADINE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; IC 50; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; QT INTERVAL; XENOPUS LAEVIS;

ANIMALS; CLONING, MOLECULAR; CRESOLS; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; MEMBRANE POTENTIALS; OOCYTES; PATCH-CLAMP TECHNIQUES; PHENYLUREA COMPOUNDS; TIME FACTORS; TRANSFECTION; XENOPUS LAEVIS;

EID: 34547542798     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.05.009     Document Type: Article

References (43)

1. Akbarali H.I., Thatte H., He X.D., Giles W.R., and Goyal R.K. Role of HERG-like K(+) currents in opossum esophageal circular smooth muscle. Am. J. Physiol. 277 (1999) C1284-C1290
2. Bianchi L., Wible B., Arcangeli A., Taglialatela M., Morra F., Castaldo P., Crociani O., Rosati B., Faravelli L., Olivotto M., and Wanke E. herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells?. Cancer Res. 58 (1998) 815-822
3. Casis O., Olesen S.P., and Sanguinetti M.C. Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol. Pharmacol. 69 (2006) 658-665
4. Chiesa N., Rosati B., Arcangeli A., Olivotto M., and Wanke E. A novel role for HERG K+ channels: spike-frequency adaptation. J. Physiol. 501 Pt 2 (1997) 313-318
5. Chouabe C., Drici M.D., Romey G., Barhanin J., and Lazdunski M. HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers. Mol. Pharmacol. 54 (1998) 695-703
6. Corrette B.J., Bauer C.K., and Schwarz J.R. An inactivating inward-rectifying K current present in prolactin cells from the pituitary of lactating rats. J. Membr. Biol. 150 (1996) 185-195
7. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., and Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 (1995) 795-803
8. De P.F., Poluzzi E., and Montanaro N. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience. Eur. J. Clin. Pharmacol. 56 (2000) 1-18
9. Emmi A., Wenzel H.J., Schwartzkroin P.A., Taglialatela M., Castaldo P., Bianchi L., Nerbonne J., Robertson G.A., and Janigro D. Do glia have heart? Expression and functional role for ether-a-go-go currents in hippocampal astrocytes. J. Neurosci. 20 (2000) 3915-3925
10. Furlan F., Guasti L., Avossa D., Becchetti A., Cilia E., Ballerini L., and Arcangeli A. Interneurons transiently express the ERG K+ channels during development of mouse spinal networks in vitro. Neuroscience 135 (2005) 1179-1192
11. Grunnet M., Jensen B.S., Olesen S.P., and Klaerke D.A. Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels. Pflugers Arch. 441 (2001) 544-550
12. Gullo F., Ales E., Rosati B., Lecchi M., Masi A., Guasti L., Cano-Abad M.F., Arcangeli A., Lopez M.G., and Wanke E. ERG K+ channel blockade enhances firing and epinephrine secretion in rat chromaffin cells: the missing link to LQT2-related sudden death?. FASEB J. 17 (2003) 330-332
13. Hansen R.S., Diness T.G., Christ T., Demnitz J., Ravens U., Olesen S.P., and Grunnet M. Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol. Pharmacol. 69 (2006) 266-277
14. Hansen R.S., Diness T.G., Christ T., Wettwer E., Ravens U., Olesen S.P., and Grunnet M. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N′-(3′-trifluoromethylphenyl)urea]. Mol. Pharmacol. 70 (2006) 1319-1329
15. Horak F., and Stubner U.P. Comparative tolerability of second generation antihistamines. Drug Saf. 20 (1999) 385-401
16. Jespersen T., Grunnet M., Angelo K., Klaerke D.A., and Olesen S.P. Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes. Biotechniques 32 536-8 (2002) 540
17. Kang J., Wang L., Cai F., and Rampe D. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide. Eur. J. Pharmacol. 392 (2000) 137-140
18. Kang J., Chen X.L., Wang H., Ji J., Cheng H., Incardona J., Reynolds W., Viviani F., Tabart M., and Rampe D. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel. Mol. Pharmacol. 67 (2005) 827-836
19. Kiehn J., Thomas D., Karle C.A., Schols W., and Kubler W. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels. Naunyn Schmiedebergs Arch. Pharmacol. 359 (1999) 212-219
20. London B., Trudeau M.C., Newton K.P., Beyer A.K., Copeland N.G., Gilbert D.J., Jenkins N.A., Satler C.A., and Robertson G.A. Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ. Res. 81 (1997) 870-878
21. Morais Cabral J.H., Lee A., Cohen S.L., Chait B.T., Li M., and Mackinnon R. Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain. Cell 95 (1998) 649-655
22. Overholt J.L., Ficker E., Yang T., Shams H., Bright G.R., and Prabhakar N.R. HERG-Like potassium current regulates the resting membrane potential in glomus cells of the rabbit carotid body. J. Neurophysiol. 83 (2000) 1150-1157
23. Papa M., Boscia F., Canitano A., Castaldo P., Sellitti S., Annunziato L., and Taglialatela M. Expression pattern of the ether-a-gogo-related (ERG) K+ channel-encoding genes ERG1, ERG2, and ERG3 in the adult rat central nervous system. J. Comp. Neurol. 466 (2003) 119-135
24. Restano-Cassulini R., Korolkova Y.V., Diochot S., Gurrola G., Guasti L., Possani L.D., Lazdunski M., Grishin E.V., Arcangeli A., and Wanke E. Species diversity and peptide toxins blocking selectivity of ether-a-go-go-related gene subfamily K+ channels in the central nervous system. Mol. Pharmacol. 69 (2006) 1673-1683
25. Rosati B., Marchetti P., Crociani O., Lecchi M., Lupi R., Arcangeli A., Olivotto M., and Wanke E. Glucose- and arginine-induced insulin secretion by human pancreatic beta-cells: the role of HERG K(+) channels in firing and release. FASEB J. 14 (2000) 2601-2610
26. Roy M., Dumaine R., and Brown A.M. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94 (1996) 817-823
27. Sacco T., Bruno A., Wanke E., and Tempia F. Functional roles of an ERG current isolated in cerebellar Purkinje neurons. J. Neurophysiol. 90 (2003) 1817-1828
28. Saganich M.J., Machado E., and Rudy B. Differential expression of genes encoding subthreshold-operating voltage-gated K+ channels in brain. J. Neurosci. 21 (2001) 4609-4624
29. Sanguinetti M.C., Curran M.E., Spector P.S., and Keating M.T. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2208-2212
30. Schafer R., Wulfsen I., Behrens S., Weinsberg F., Bauer C.K., and Schwarz J.R. The erg-like potassium current in rat lactotrophs. J. Physiol. 518 Pt 2 (1999) 401-416
31. Shi W., Wymore R.S., Wang H.S., Pan Z., Cohen I.S., McKinnon D., and Dixon J.E. Identification of two nervous system-specific members of the erg potassium channel gene family. J. Neurosci. 17 (1997) 9423-9432
32. Shoeb F., Malykhina A.P., and Akbarali H.I. Cloning and functional characterization of the smooth muscle ether-a-go-go-related gene K+ channel. Potential role of a conserved amino acid substitution in the S4 region. J. Biol. Chem. 278 (2003) 2503-2514
33. Snyders D.J., and Chaudhary A. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol. Pharmacol. 49 (1996) 949-955
34. Suessbrich H., Schonherr R., Heinemann S.H., Attali B., Lang F., and Busch A.E. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br. J. Pharmacol. 120 (1997) 968-974
35. Tie H., Walker B.D., Valenzuela S.M., Breit S.N., and Campbell T.J. The heart of psychotropic drug therapy. Lancet 355 (2000) 1825
36. Titus S.A., Warmke J.W., and Ganetzky B. The Drosophila erg K+ channel polypeptide is encoded by the seizure locus. J. Neurosci. 17 (1997) 875-881
37. Wang X.J., Reynolds E.R., Deak P., and Hall L.M. The seizure locus encodes the Drosophila homolog of the HERG potassium channel. J. Neurosci. 17 (1997) 882-890
38. Warmke J.W., and Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3438-3442
39. Wimmers S., Wulfsen I., Bauer C.K., and Schwarz J.R. Erg1, erg2 and erg3 K channel subunits are able to form heteromultimers. Pflugers Arch. 441 (2001) 450-455
40. Wimmers S., Bauer C.K., and Schwarz J.R. Biophysical properties of heteromultimeric erg K+ channels. Pflugers Arch. 445 (2002) 423-430
41. Zeng H., Lozinskaya I.M., Lin Z., Willette R.N., Brooks D.P., and Xu X. Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator. J. Pharmacol. Exp. Ther. 319 (2006) 957-962
42. Zhou Z., Gong Q., Ye B., Fan Z., Makielski J.C., Robertson G.A., and January C.T. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys. J. 74 (1998) 230-241
43. Zhou J., Augelli-Szafran C.E., Bradley J.A., Chen X., Koci B.J., Volberg W.A., Sun Z., and Cordes J.S. Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity. Mol. Pharmacol. 68 (2005) 876-884